Peg‐interferon and ribavirin treatment in HIV/HCV co‐infected patients in Thailand: efficacy, safety and pharmacokinetics von Smolders, E. J., Thammajaruk, N., Kanter, C. T. M. M., Colbers, A., Chaiyahong, P., Cuprasitrut, T., Chittmittraprap, S., Apornpong, T., Khemnark, S., Tangkijvanich, P., Burger, D. M., Avihingsanon, A.

Volltext

Ribavirin steady‐state plasma level is a predictor of sustained virological response in hepatitis C–infected patients treated with direct‐acting antivirals von Tilborg, M., Lieveld, F. I., Smolders, E. J., Erpecum, K. J., Kanter, C. T. M. M., Maan, R., Valk, M., Arends, J. E., Dofferhoff, A. S. M., Blokzijl, H., Bijmolen, M., Drenth, J. P. H., Knegt, R. J., Burger, D. M.

Volltext

Busulfan target exposure attainment in children undergoing allogeneic hematopoietic cell transplantation: a single day versus a multiday therapeutic drug monitoring regimen von Bognàr, T. (Tim), Kingma, J. S. (Jurjen), Smeijsters, E. H. (Erin), van der Elst, K. C. M. (Kim), de Kanter, C. T. M. (Klaartje), Lindemans, C. A. (Caroline), Egberts, A. C. G. (Toine), Bartelink, I. H. (Imke), Lalmohamed, A. (Arief)

Volltext

Decreased tacrolimus plasma concentrations during HCV therapy: a drug–drug interaction or is there an alternative explanation? von Smolders, E.J, Pape, S, de Kanter, C.T.M.M, van den Berg, A.P, Drenth, J.P.H, Burger, D.M

Volltext

Pharmacokinetics of two generic co-formulations of lopinavir/ritonavir for HIV-infected children: a pilot study of paediatric Lopimune versus the branded product in healthy adult v... von de Kanter, C. T. M. M., Colbers, E. P. H., Fillekes, Q., Hoitsma, A., Burger, D. M.

Volltext

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications von Smolders, E. J., de Kanter, C. T. M. M., de Knegt, R. J., van der Valk, M., Drenth, J. P. H., Burger, D. M.

Volltext

Stroke in infective endocarditis von HART, R. G, FOSTER, J. W, LUTHER, M. F, KANTER, M. C

Volltext

Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90 mg in a patient with severe epilepsy on oxcarbazepine von Smolders, E.J, de Kanter, C.T.M.M, van 't Veer, N, D'avolio, A, Di Perri, G, Burger, D.M, van Wijngaarden, P

Volltext

Daclatasvir 30 mg/day is the correct dose for patients taking atazanavir/cobicistat von Smolders, E J, Colbers, E P H, de Kanter, C T M M, Velthoven-Graafland, K, Drenth, J P H, Burger, D M

Volltext

Hematologic disorders and ischemic stroke : a selective review von HART, R. G, KANTER, M. C

Volltext

Anterior ischemic optic neuropathy is not associated with carotid artery atherosclerosis von FRY, C. L, CARTER, J. E, KANTER, M. C, TEGELER, C. H, TULEY, M. R

Volltext

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomis... von Stroke Prevention in Atrial Fibrillation Investigators

Volltext

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications von Smolders, E. J, de Kanter, C. T M M, de Knegt, R. J, van der Valk, M, Drenth, J. P H, Burger, D. M

Volltext

Lack of a clinically significant drug-drug interaction in healthy volunteers between the HCV protease inhibitor boceprevir and the proton pump inhibitor omeprazole von de Kanter, Clara T M M, Colbers, Angela P H, Blonk, Maren I, Verweij-van Wissen, Corrien P W G M, Schouwenberg, Bas J J W, Drenth, Joost P H, Burger, David M

Volltext

Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study von Halperin, J L, Hart, R G, Kronmal, R A, McBride, R

Volltext

Cerebral mycotic aneurysms are rare in infective endocarditis von Kanter, Merrill C., Hart, Robert G.

Volltext

Strategies for preventing stroke von Kanter, M C, Sherman, D G

Volltext

Ancrod for the treatment of acute ischemic brain infarction von Ancrod Stroke Study Investigators

Volltext

NEUROBEHAVIORAL CHANGE AND AERIC EMBOLI von Mitzel, H. C., Bunegin, L., Albin, M. S., Kanter, M. C.

Volltext

Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90 mg in a patient with severe epilepsy on oxcarbazepine von Smolders, E J, de Kanter, C T M M, van 't Veer, N, D'avolio, A, Di Perri, G, Burger, D M, van Wijngaarden, P

Volltext